drugset / Trial / NCT06967376

The Role of Adjuvant Corneal Crosslinking in the Management of Infective Keratitis

NCT06967376

Phase 0 Completed 40 enrolled Research Institute of Ophthalmology, Egypt
RandomizedParallel-groupSingle-blindTreatment

Summary

This was a prospective, single centre, randomised controlled study to evaluate the clinical effectiveness of corneal collagen crosslinking as an adjuvant to antimicrobial therapy.

Timeline

Start
2018-05-21
Primary completion
2021-11-11
Completion
2022-02-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ceftazidime Small molecule 50 mg/ml Topical
Comparator Itraconazole Small molecule 100 mg Oral
Comparator Vancomycin Other / unclassified 50 mg/ml Topical

Indications